Kristina Amato
Nurse Practitioner · Hartford, CTNPI 1750699369
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 282 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 16 manufacturers, the largest accounting for just 20.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $2,005 and has fallen 99.2% since, to $16 in 2024. Among nurse practitioner clinicians in CT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 282 payments — averaging $16.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$955
- AbbVie$897
- Takeda Pharmaceuticals U.S.A., Inc.$814
- Bristol Myers Squibb$489
- Johnson & Johnson$377
- Nestle Healthcare Nutrition Inc.$348
- plus $871 from 10 others
What the payments were for
- Food & beverage$4,752100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 62 | $955 |
| AbbVie | 56 | $897 |
| Takeda Pharmaceuticals U.S.A., Inc. | 47 | $814 |
| Bristol Myers Squibb | 30 | $489 |
| Johnson & Johnson(2 entities) | 18 | $377 |
| Nestle Healthcare Nutrition Inc. | 20 | $348 |
| Ardelyx, Inc. | 10 | $179 |
| Ironwood Pharmaceuticals, Inc | 8 | $155 |
| QOL Medical, LLC | 9 | $144 |
| Redhill Biopharma Inc. | 7 | $125 |
| Gilead | 7 | $111 |
| Regeneron Healthcare Solutions, Inc. | 2 | $49 |
| Merck | 2 | $40 |
| Daiichi Sankyo Inc. | 2 | $38 |
| Alnylam Pharmaceuticals Inc. | 1 | $15 |
| Alfasigma USA, Inc. | 1 | $14 |
How this compares
$4,752 in reported general payments places this provider in the 95th percentile of 1,162 nurse practitioner providers in Connecticut.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XifaxanRifaximin | 13 | $39,287 |
| LinzessLinaclotide | 15 | $17,823 |
| Mesalamine | 13 | $3,219 |
| Sucralfate | 17 | $2,585 |
| Pantoprazole Sodium | 104 | $1,300 |
| Famotidine | 67 | $972 |
| Dicyclomine Hcl | 13 | $309 |
| Omeprazole | 18 | $256 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan | $955 | $39,28713 claims |
| AbbVieLinzess | $897 | $17,82315 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,162 nurse practitioner providers in Connecticut.
Other nurse practitioner in Hartford
- Patricia BozemanHartford$11K
- Annette EpplerHartford$10K
- Angel RentasHartford$8K
- Angela BoisseauHartford$5K
- John Martin-BeaulieuHartford$5K
- Sandra PalmerHartford$4K
- Lindita VincaCheshire$427K
- Catherine MilnePlymouth$361K
- Michele NovellaDanbury$331K
- Tiffany RydzNewtown$49K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.